Radium Ra 223 dichloride

FDA Drug Profile — Xofigo

Drug Details

Generic Name
Radium Ra 223 dichloride
Brand Names
Xofigo
Application Number
NDA203971
Sponsor
Bayer HealthCare Pharmaceuticals Inc.
NDC Codes
1
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
RADIUM RA-223 DICHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Xofigo is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. Xofigo is an alpha particle-emitting radioactive therapeutic agent indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. ( 1 )